[Relationship between changes in biochemical markers of bone turnover and prediction value of fracture risk].
The change in BMD is poor predictor of vertebral fracture risk after Raloxifene treatment, whereas bone turnover markers were significantly associated with fracture risk. The percent change in osteocalcin (OC) was better able to predict the reduction in vertebral fracture risk than the percent change in femoral neck BMD in patients treated with Raloxifene in MORE study.